Toxys
Latest round
- Series A
Last raised
- Feb 2016
Total raised
- Undisclosed
Investors
- 2
About Toxys
V.V. is based in Leiden, Netherlands, and provides innovative solutions for toxicity testing.Toxys specializes in in vitro toxicity screening solutions designed to identify hazardous and potential carcinogenic properties of novel compounds. Key offerings include the ToxTracker and ReproTracker assays, which help assess the genotoxic and teratogenic properties of substances.Revenue is generated through partnerships and contracts with pharmaceutical and chemical clients who use Toxys' bespoke testing services, including ToxTracker and ReproTracker assays.V. The company plans to expand its product offerings, including potential new assays and enhancements to existing products.
Who invested in Toxys
2 investors across 1 round
See all investors in Toxys
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 18, 2016
Amount
Undisclosed
Investors
Questions about Toxys
Who invested in Toxys?
Toxys has 2 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Toxys raised?
Toxys has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Toxys last raise money?
Toxys's most recent round on record is a Series A, in Feb 2016.
What does Toxys do?
Toxys is a biotechnology company.
Where is Toxys headquartered?
Toxys is headquartered in Leiden, Netherlands.
Which VCs invest in companies like Toxys?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back biotechnology companies at Toxys's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Toxys? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.